Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.
Hassan YousefiManinder KhoslaLothar LauterboeckSamuel C OkpechiDavid WorthylakeJone GaraiJovanny ZabaletaJessie GuidryMohammad Amin ZarandiDorota WyczechowskaJanarthanan JayawickramarajahQinglin YangJoseph KissilSuresh K AlahariPublished in: Oncogene (2023)